Skip to Content

NATCO 30 (Lansoprazole Delayed-Release 30 mg)

Pill with imprint NATCO 30 is Blue & Pink, Capsule-shape and has been identified as Lansoprazole Delayed-Release 30 mg. It is supplied by Breckenridge Pharmaceutical, Inc..

Lansoprazole is used in the treatment of barrett's esophagus; duodenal ulcer; duodenal ulcer prophylaxis; gerd; erosive esophagitis and belongs to the drug class proton pump inhibitors. There is no proven risk in humans during pregnancy. Lansoprazole 30 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for NATCO 30

Lansoprazole delayed-release 30 mg NATCO 30
Lansoprazole delayed-release 30 mg NATCO 30
Lansoprazole delayed-release 30 mg NATCO 30
Lansoprazole delayed-release 30 mg NATCO 30

Lansoprazole Delayed-Release

Imprint
NATCO 30
Strength
30 mg
Color
Blue & Pink
Shape
Capsule-shape
Availability
Rx and/or OTC
Drug Class
Proton pump inhibitors
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Breckenridge Pharmaceutical, Inc.

Labelers / Repackagers

NDC CodeLabeler / Repackager
51991-0772 Breckenridge Pharmaceutical, Inc.
45963-0461 Actavis Pharma, Inc.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.